Ekso Bionics Holdings

EKSO65

Penny Stock

$1.21arrow_drop_down1.21%-$0.01

Penny Stock

EKSO65

$1.21

arrow_drop_down1.21%-$0.01

Penny Stock

Performance History

Key Stats
Open	$1.22
Prev. Close	$1.23
EPS	-0.79
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$26.49M
PE Ratio	-

	LOW	HIGH
Day Range	1.20	1.23
52 Week Range	0.62	3.12

Ratios







EPS	-0.79

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ekso Bionics Holdings (EKSO)

Ekso Bionics Holdings Inc (EKSO) is a leading developer and manufacturer of exoskeleton technology for medical and industrial use. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics has revolutionized the field of wearable robotics with its innovative exoskeleton designs that assist individuals with mobility impairments and enhance human strength and endurance in industrial settings. The company's mission is to empower individuals to reach their full potential and improve their quality of life through the use of exoskeleton technology.

Ekso Bionics' flagship product, the EksoGT, is a robotic exoskeleton that enables individuals with spinal cord injuries and other neurological disorders to walk again. By providing powered assistance to the legs, the EksoGT helps users regain mobility and independence. The exoskeleton is designed to be adjustable and customizable to fit the needs of each individual user. In addition to the medical field, Ekso Bionics' exoskeletons are also used in industrial applications to enhance worker safety and productivity.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Scott G. Davis
Headquarters: San Rafael
Employees: 72
Exchange: NASDAQ

Keep an eye on Ekso Bionics Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ekso Bionics Holdings 's (EKSO) price per share?

The current price per share for Ekso Bionics Holdings (EKSO) is $1.22. The stock has seen a price change of -$0.02 recently, indicating a -1.22% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ekso Bionics Holdings (EKSO)?

For Ekso Bionics Holdings (EKSO), the 52-week high is $3.13, which is 157.53% from the current price. The 52-week low is $0.62, the current price is 95.34% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ekso Bionics Holdings (EKSO) a growth stock?

Ekso Bionics Holdings (EKSO) has shown an average price growth of 0.41% over the past three years. It has received a score of 12 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ekso Bionics Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Ekso Bionics Holdings (EKSO) stock price performance year to date (YTD)?

As of the latest data, Ekso Bionics Holdings (EKSO) has a year-to-date price change of -60.81%. Over the past month, the stock has experienced a price change of 10.45%. Over the last three months, the change has been 21.5%. Over the past six months, the figure is -16.21%. Looking at a longer horizon, the five-year price change stands at -83.96%.

help

Is Ekso Bionics Holdings (EKSO) a profitable company?

Ekso Bionics Holdings (EKSO) has a net income of -$15.2M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 53.06% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -47.17% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $18.28M, with a revenue growth rate of 41.57%, providing insight into the company's sales performance and growth. The gross profit is $9.7M. Operating income is noted at -$15.11M. Furthermore, the EBITDA is -$10.31M.

help

What is the market capitalization of Ekso Bionics Holdings (EKSO)?

Ekso Bionics Holdings (EKSO) has a market capitalization of $26.5M. The average daily trading volume is 74.69K, indicating the stock's liquidity and investor engagement.